Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1-Reference-Cited by-同舟云学术

Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1

Published:2018-01-19 Issue:6 Volume:65 Page:e26963
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Mauro Margherita¹,Saggiorato Graziella²,Sartori Maria Teresa²,Gallo Giuseppe¹,De Bortoli Massimiliano¹,Bonetti Elisa¹,Zaccaron Ada¹,Vitale Virginia¹,Balter Rita¹,Chinello Matteo¹,Cesaro Simone¹^ORCID

Affiliation:

1. Pediatric Hematology Oncology; Azienda Ospedaliera Universitaria Integrata; Verona Italy

2. Department of Medicine, Clinical Medicine I, University of Padova; Italy

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation (EBMT);Corbacioglu;Bone Marrow Transpl,2017

2. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European society for blood and marrow transplantation;Mohty;Bone Marrow Transpl,2016

3. Sinusoidal obstruction syndrome during chemotherapy of pediatric cancers and its successful management with defibrotide;Kizilocak;J Pediatr Hematol Oncol,2017

4. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome;Helmy;Aliment Pharmacol Ther,2006

5. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation;Akil;Biol Blood Marrow Transpl,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature;Pediatric Hematology and Oncology;2024-08-28

2. A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome;PLOS ONE;2023-04-05

3. Treatment of Sinusoidal Obstruction Syndrome With Defibrotide in Pediatric Cancer Patients Following Nontransplant-associated Chemotherapy;Journal of Pediatric Hematology/Oncology;2021-04-26

4. Nutrigenomics Approaches to Control Metabolic Diseases and Challenges to Personalized Nutritional Intervention;Advances in Agri-Food Biotechnology;2020

5. PAI‐1 and protein C as early markers of veno‐occlusive disease in patients treated for Wilms tumor;Pediatric Blood & Cancer;2019-03-13